Skip to main content
. 2012 Sep 6;107(8):1286–1294. doi: 10.1038/bjc.2012.388

Figure 2.

Figure 2

Progression-free survival (PFS) for patients with negative or equal 0 vs positive ΔAUC. Progression-free survival was measured as the time between the baseline CTC assessment and documentation of first radiographic evidence of disease progression or death. The ΔAUC criterion represents the difference between live and apoptotic CTC concentration-time area and was calculated in all patients according to the following formula: Inline graphic